Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04750278
Status:
TERMINATED
Last Update Posted:
2024-01-05
First Post:
2021-02-02
Brief Title:
A Phase 23 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19
Sponsor:
Foresee Pharmaceuticals Co Ltd
Organization:
Foresee Pharmaceuticals Co Ltd
Organization Data
Organization:
Foresee Pharmaceuticals Co Ltd
Class:
INDUSTRY
Study ID:
FP02C-20-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Foresee Pharmaceuticals Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None